EFFECTIVENESS AND SAFETY OF IBRUTINIB IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA TREATED IN ITALY ACCORDING TO THE IBRUTINIB NAMED PATIENT PROGRAM: THE REAL LIFE RESULTS

HAEMATOLOGICA(2017)

引用 0|浏览25
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要